Your session is about to expire
← Back to Search
Perfusion Enhancement System
Study Arm for Ischemic Stroke
N/A
Waitlist Available
Led By Fern Cudlip, MSN FNP CNRN
Research Sponsored by TurnCare Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the time frame will be up to and including 24 months
Awards & highlights
Summary
This trial is testing a new device called The Guardian System, which helps improve blood flow in stroke patients. It uses inflatable surfaces on beds and chairs to enhance circulation. The study aims to see if this device can help stroke patients recover better and leave the hospital sooner.
Eligible Conditions
- Ischemic Stroke
- Stroke
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ the time frame will be up to and including 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the time frame will be up to and including 24 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Length of Stay Reduction in Acute Ischemic Stroke Patients in the Control and Study Arm Groups
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Study ArmExperimental Treatment1 Intervention
The Study Arm will have the non-invasive perfusion enhancement system placed on their beds and recovery chairs. Patients will be utilizing the systems while lying in bed or sitting in the chair.
Group II: Control GroupActive Control1 Intervention
The Control Group will receive the standard support surface mattresses/bed surfaces and recovery chairs without the non-invasive perfusion enhancement system (The Guardian System)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Guardian System
2008
Completed Phase 3
~1020
Find a Location
Who is running the clinical trial?
TurnCare Inc.Lead Sponsor
1 Previous Clinical Trials
431 Total Patients Enrolled
Fern Cudlip, MSN FNP CNRNPrincipal InvestigatorGood Samaritan Hospital
Share this study with friends
Copy Link
Messenger